Endocrine disrupting properties of perfluorooctanoic acid - Test2 - elhamkhani - TriplyDB

Endocrine disrupting properties of perfluorooctanoic acid

Endocrine disrupting properties of perfluorooctanoic acid

http://www.wikidata.org/entity/Q24633469

about

Exposure to triclosan augments the allergic response to ovalbumin in a mouse model of asthma The Navigation Guide - evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth The epigenetic lorax: gene-environment interactions in human health Effects of Environmental Exposures on Fetal and Childhood Growth Trajectories The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals Prostate-specific antigen and perfluoroalkyl acids in the C8 health study population Endocrine-disrupting chemicals: associated disorders and mechanisms of action Association between perfluoroalkyl acids and kidney function in a cross-sectional study of adolescents Endocrine, biotransformation, and oxidative stress responses in salmon hepatocytes exposed to chemically induced hypoxia and perfluorooctane sulfonamide (PFOSA), given singly or in combination.Perfluorooctanoate and neuropsychological outcomes in children Environmental endocrine disruption of energy metabolism and cardiovascular risk.Effect of BMI on cardiovascular and metabolic syndrome risk factors in an Appalachian pediatric population The Navigation Guide systematic review methodology: a rigorous and transparent method for translating environmental health science into better health outcomes The Navigation Guide - evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth.Changing interpretation of human health risks from perfluorinated compounds Prenatal perfluorooctanoic acid exposure in CD-1 mice: low-dose developmental effects and internal dosimetry Perfluorochemical (PFC) exposure in children: associations with impaired response inhibition Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age.Involvement of NRF2 in Perfluorooctanoic Acid-Induced Testicular Damage in Male Mice.Advancing research on endocrine disrupting chemicals in breast cancer: Expert panel recommendations.The mammary gland is a sensitive pubertal target in CD-1 and C57Bl/6 mice following perinatal perfluorooctanoic acid (PFOA) exposure.Endocrine disruption of the epigenome: a breast cancer link.Histopathologic changes in the uterus, cervix and vagina of immature CD-1 mice exposed to low doses of perfluorooctanoic acid (PFOA) in a uterotrophic assay.Perfluorooctanoic acid effects on ovaries mediate its inhibition of peripubertal mammary gland development in Balb/c and C57Bl/6 mice Perfluorooctanoate exposure in a highly exposed community and parent and teacher reports of behaviour in 6-12-year-old children.Effect of temperature and duration of storage on the stability of polyfluoroalkyl chemicals in human serum.Perinatal environmental exposures affect mammary development, function, and cancer risk in adulthood Prenatal perfluoroalkyl substance exposure and child adiposity at 8 years of age: The HOME study.Exposure to PFOA and PFOS and fetal growth: a critical merging of toxicological and epidemiological data.Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010 Programming of metabolic effects in C57BL/6JxFVB mice by in utero and lactational exposure to perfluorooctanoic acid Hypercholesterolemia with consumption of PFOA-laced Western diets is dependent on strain and sex of mice Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children Endocrine disruptors and the breast: early life effects and later life disease Prenatal Exposure to Perfluoroalkyl Substances and Behavioral Development in Children.Association between perfluoroalkyl substances and thyroid stimulating hormone among pregnant women: a cross-sectional study.Environmental Factors Impacting Bone-Relevant Chemokines.Neurotoxic effects of perfluoroalkylated compounds: mechanisms of action and environmental relevance.

P2860

Q23921566-A3F655D1-7BCD-4EF3-AA9E-511EBF4CC734 Q26851809-7CE9DD0F-0342-4C73-9097-16BD67CFA980 Q26853148-3DFCC90E-8D02-48E7-8237-0675C7E40DDC Q28079540-459EC9D9-3619-4936-8D7E-1638B364813B Q28079984-9E62DBE1-F15A-49A0-8B45-58EBFD8077AC Q28383132-89EC46C2-4F24-44C0-8CE1-0540D5B4F0CE Q28384774-8E006ACD-B8A4-4490-8ACF-659F1A4C9FDE Q28388657-4DBB716F-21A7-4185-9DCB-EDC5640C9D72 Q28394440-CFD06B6C-4FB7-4ED1-ADA4-68BCE37BC299 Q30874167-7D4A0541-0AE8-41EA-AAA2-DD319EA1814D Q33608031-4E317158-555D-44E6-9DD2-BA56581C503B Q33794195-7D383CC7-C4CE-4BFC-9658-E04B4F6D5F7E Q34273663-E6A72A29-EC2F-4720-A37C-2CD5ACCAC585 Q34275302-A0922575-151F-4D08-A464-3DD35B6E64DD Q34275367-AFA90178-DBC7-45BF-8F4B-1B28CB8AA65F Q34296310-9209771B-BB10-488D-BA9D-D85E86D27C2B Q35127685-7FAD8548-3DF4-4961-B34F-6CC4CD44B50A Q35249221-99E7AA1A-A815-45F0-8E77-C84F7A294036 Q35562877-6C48D946-32A2-4C4C-9B6A-2B41EAE80809 Q35591930-81CDFBEA-40D4-4715-A3A6-9F23EC42B865 Q35673553-E727316F-424E-44C5-AAEA-A8C529CFF27C Q35732620-E0902578-F6C9-4F57-8170-EF0799432678 Q35732800-0D746315-F5AB-4253-883D-CA0F8E63ACA9 Q35856594-8D5AB067-B090-4A93-914D-796038B6C8B7 Q35996126-9BEF60E3-915D-45D8-AFA1-BB1D8884BC0A Q35996130-065EC79A-9793-44BC-A24A-EE2A405ECA94 Q36198328-386CD45C-1F9E-4A7E-90BD-F095C70FD16A Q36239549-E6176CA5-1AAD-4377-8B05-FB3B5B9F8321 Q36336669-6AC3E271-6456-4A36-B311-2FC1B8B42B3B Q36396103-EC31D189-8D07-47D8-A586-F9A51983736E Q36406073-6DFEBA8D-C6CE-4A17-B2B2-D6F04425DD79 Q36456151-43E27DE3-EFC3-49CB-8D16-6D1CF766FD65 Q36582254-ED7C2556-A057-4E76-825C-261F0167401C Q36629792-1FE3F866-32B1-401F-A1B4-C69677EE438F Q36814940-89AB9F55-05E3-42C6-84D9-97235CB312FB Q36929670-9EC50359-3109-4B40-B212-C2A7399BB979 Q36938040-11B8B48F-C057-45B5-95C8-C230FAA18CC8 Q37357430-2E73B4A8-4238-4524-BA43-18207409B44A Q37639340-E0E48D81-76D3-4431-A2EF-91F9E60551B2 Q37997949-0297783D-F22E-4882-922B-A77C2FE8D54D

P2860

Endocrine disrupting properties of perfluorooctanoic acid

http://www.wikidata.org/entity/Q24633469

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Endocrine disrupting properties of perfluorooctanoic acid

@ast

Endocrine disrupting properties of perfluorooctanoic acid

@en

Endocrine disrupting properties of perfluorooctanoic acid

@nl

type

label

Endocrine disrupting properties of perfluorooctanoic acid

@ast

Endocrine disrupting properties of perfluorooctanoic acid

@en

Endocrine disrupting properties of perfluorooctanoic acid

@nl

prefLabel

Endocrine disrupting properties of perfluorooctanoic acid

@ast

Endocrine disrupting properties of perfluorooctanoic acid

@en

Endocrine disrupting properties of perfluorooctanoic acid

@nl

P1433

Q24633469-FC279617-2BB2-4465-A62C-1D523B9EE235

P1476

Q24633469-F39521BA-19AA-4092-8092-A2376F5B8299

P2093

Q24633469-5DF0D919-2004-48C8-B72A-008FB47FBBD4

Q24633469-7CC9FB35-20BF-487D-987B-C022597B061C

P2860

Q24633469-038B9274-3C6A-46BE-9B50-9E592CED368F

Q24633469-06E684EF-E66B-4E7A-A581-F4545B9AAC99

Q24633469-08C4421E-A09A-4D6A-B68C-E8D2CE8684E7

Q24633469-08E8D77B-40BC-46E7-8F79-F52F58D1C8AC

Q24633469-095EC719-D240-4473-843B-D3DFDAD06B69

Q24633469-0A897FAC-1AD3-449A-81DF-73AC54460FEB

Q24633469-0B24C48F-1DD2-460B-B8B7-2010612AFA14

Q24633469-0D921C7E-3F84-4E42-87D1-770912B16C6D

Q24633469-0FA07CBC-55E6-4C6C-945A-D0521E2DFEA4

Q24633469-0FA3DBB0-F54C-4A77-8D48-AC8EF97C62D8

P304

Q24633469-89B156B3-CB20-42FE-B914-A2BE867DC360

P31

Q24633469-FDF6939C-9B32-450A-9300-98FC8E2C49CE

P3181

Q24633469-993506CB-E08F-4729-8173-53DE2C627029

P356

Q24633469-674E3C4C-684F-4676-BE28-271189799B3B

P407

Q24633469-88D224E9-1443-40E2-91A7-690BBF746E19

P433

Q24633469-30CFC3CA-0865-4946-B089-8DC1430B297A

P478

Q24633469-D1481121-749D-4749-A75D-A9A5A9C099FF

P50

Q24633469-B9C3EE95-EE27-48A1-B35C-A7E458058B98

P577

Q24633469-D19F6999-5868-4021-9EE3-8025F8463E09

P5875

Q24633469-306B1ADE-F388-4227-8030-C7792B4BB810

P698

Q24633469-57808E43-10F8-4358-B751-0204B5E2FD9E

P921

Q24633469-B6B84345-BD4C-46C5-9D81-7536C77D9C95

P932

Q24633469-C33E30F7-4C1D-4A4F-BBBC-76BDA635B581

P3181

P356

J.JSBMB.2011.03.011

P1433

The Journal of Steroid Biochemistry and Molecular Biology

P1476

Endocrine disrupting properties of perfluorooctanoic acid

@en

P2093

Sally S White

http://www.w3.org/2001/XMLSchema#string

Suzanne E Fenton

http://www.w3.org/2001/XMLSchema#string

P2860

Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha

The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water

Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey

Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age

Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA)

Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia

Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population

Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth

Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy

The C8 health project: design, methods, and participants

P304

16-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1494182

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.JSBMB.2011.03.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50375895

http://www.w3.org/2001/XMLSchema#string

P698

21397692

http://www.w3.org/2001/XMLSchema#string

P921

P932

3335904

http://www.w3.org/2001/XMLSchema#string